Robert Niichel (Bob) is the Founder and CEO of SmartTab, a digital medicine company developing novel and effective wireless drug delivery and monitoring systems. In this episode, Bob discusses the reimagination of capsules to produce a wireless smart ingestible capsule as a platform for personalised, biologically targeted drug delivery. He talks about what the key problems are with existing drug delivery methods and how the SmartTab offers to deliver a better patient experience, whilst supporting better clinical workflows and healthcare outcomes.
Key takeaways:
- SmartTab is bringing about a convergence of technologies to produce a capsule that can be remotely controlled or pre-programmed to achieve a therapeutic goal within our bodies in the right place, at the right time and the right dosage.
- SmartTab and SmartCapsule have the potential to be used by healthcare innovators to develop digital therapeutics, digital medicine or other scaled healthcare service delivery models across our entire population anywhere, anytime.
- SmartTab is essentially a technology platform. Each capsule shares about 80% of the same internal components as one another for communication, power, etc. SmartTab’s approach to novel and more effective therapies helps improve patient outcomes and compliance. And, it is likely to shape the way we move forward with digital health.
Resources and links:
Connect:
